IPFA 和 PEI 很高兴地宣布，第28 届血源性病原体监测和筛查国际研讨会将于 2022 年 9 月 21 日至 22 日再次举行第 28 届研讨会将在葡萄牙美丽的波尔图市举行，完全是现场活动。与以前的版本一样，研讨会将讨论威胁血液成分和血浆药物安全的新旧药物的检测、灭活和流行病学。科学计划将侧重于血液和血浆采集机构特别感兴趣的项目。

包括的主题有：

• 冠状病毒/Sarbecovirus 的演变和前景

• 从 SARS-Cov-2 大流行中吸取的教训

• 血液筛查技术的更新

• 大流行的监测和准备

• MSM 和其他捐赠者延期问题。

• vCJD 和其他朊病毒疾病

• 制造商会议

谁应该参加？

一年一度的 IPFA/PEI 研讨会被公认为是讨论和评估由传染性病原体引起的可能对血液成分和血浆药物的安全性产生影响的所有类型风险的主要活动。该研讨会对所有有兴趣维护接受血液成分或血浆药物治疗的患者安全的专业人员都很有价值。

这包括：

• 血液机构

• 医生和医疗保健提供者

• 制药、诊断和其他相关行业

• 监管机构

• 患者组织

• 学术界

我们热忱欢迎您出席本次会议，并期待来自世界各地的积极参与！

注册费包括全员参加研讨会、两天的茶歇和午餐，以及活动结束后的在线会议记录。

Wednesday 21 September

09:00 - 10:10 - Session 1

Welcome, Introduction and Keynote Presentation

·       09:00 - 09:10 Welcome and Introduction - IPFA & PEI

·       09:10 - 09:30 Presentation by IPST on Portuguese Blood Service

·       09:30 - 10:00 Keynote Presentation – SARS-COV-2: From the Proximal Ancestors in Bats to Pandemic Variants in Humans - Marc Eloit, Institut Pasteur, France

·       10:00 - 10:10 Q&A

10:10 - 10:30 Coffee Break

10:30 - 12:00 - Session 2

Role of Blood Donors in Pandemic Surveillance

·       10:30 – 10:50 Blood Donors for SARS CoV-2 Serosurveillance - Christian Erikstrup, Aarhus University Hospital, Denmark

·       10:50 – 11:10 Evolution of Donor Serosurveillance from Cross-Sectional to Longitudinal Approaches - Mike Busch, VRI/UCSF (United States)

·       11:10 – 11:30 Serosurveillance in Brazil - Ester Sabino, Universidade São Paulo, Brazil

·       11:30 – 11:50 Serosurveillance of SARS-CoV-2 in Frequent Plasma Donors - Marc Germain, Héma-Québec, Canada

·       11:50 - 12:05 Q&A

12:00 - 12:30 IPFA Award

·       12:05 - 12:15 Introduction of the IPFA Award Winner and Presentation of the Award

·       12:15 - 12:30 Presentation by de Award Winner

12:30 - 14:00 Lunch

14:00 - 15:30 - Session 3

COVID-19 – Transfusion Safety and Blood-Derived Therapeutics

·       14:00 - 14:20 Pros and Cons of Different Animal Models of SARS-CoV-2 Infection - Koen Van Rompay, University of California, United States

·       14:20 – 14:40 Passive Immunotherapy - Focus on CCP and HyperIg - Lise Estcourt, NHSBT Oxford, England

·       14:40 - 15:00 COVID-19 Implication for Transfusion: Risks from the Virus or from the Antibodies? - Pierre Tiberghien, Etablissement Français du Sang, France

·       15:00 - 15:20 Omicron, SARS-CoV-2 Neutralising Antibodies in US and EU Plasma and Cross Reactivity with Seasonal Corona Viruses - Thomas Kreil, Takeda

·       15:20 - 15:30 Q&A

15:30 - 16:00 Coffee Break

16:00 - 17:35 - Session 4

vCJD and Prion Diseases

·       16:00 – 16:20 Introduction to Prions - Hans Zaaijer, Sanquin, the Netherlands

·       16:20 – 16:40 European Medicines Agency/ECDC Updates on Risk Assessments - Speaker to be Confirmed

·       16:40 – 17:00 Development of Diagnostic Tests for vCJD and other Proteinopathies - Daisy Bougard, Etablissement Français du Sang, Montpellier, France

·       17:00 – 17:20 What is the vCJD Risk for Blood Safety in the UK Donor Population? - Richard Knight, UK CJD Surveillance Unit

·       17:20 - 17:35 Q&A

18:30 - 22:30

Dinner at the Real Ca Velha Port Wine Cellars

Join us for an exceptional dinner at the Real Ca Velha Port Wine Cellars. The evening will start with a guided tour through the Port Cellar and includes a Port tasting. After this, you can enjoy a three-course seated dinner. Busses from the Crowne Plaza will depart at 18:30 and return at 22:30. Tickets to be purchased during the registration process (€75)

Thursday 22 September

09:00 - 10:20 - Session 5

Manufacturer’s Session

·       09:00 - 09:20 - Abbott

·       09:20 - 09:40 - Roche

·       09:40 - 10:00 - TBA

·       10:00 - 10:20 - PCL Inc.

10:20 - 10:45 Coffee Break

10:45 - 12:15 - Session 6

MSM and Other Donor Deferral/Recruitment Issues

·       10:45 – 10:55 Introduction - Brian Custer, VRI/UCSF (United States)

·       10:55 – 11:15 Relaxation of MSM Deferral Criteria in The Netherlands: Current Experience and the Next Steps - Thijs van de Laar, Sanquin, the Netherlands

·       11:15 – 11:35 Donor Eligibility/Deferral Issues including Donation by MSM in Canada, outside of Quebec - Mindy Goldman, Canada

·       11:35 – 11:55 Donor Selection and Impact of FAIR within NHSBT - Su Brailsford, NHSBT, England

·       11:55 - 12:15 Q&A

12:15 - 13:45 Lunch

13:45 - 15:15 - Session 7

Update Session including Emerging Pathogens

·       13:45 - 14:05 HEV Update in Europe - Heli Harvala Simmonds, NHS Blood and Transplant, United Kingdom

·       14:05 - 14:25 Hepatitis B - Speaker to be Confirmed

·       14:25 - 14:45 Malaria/Babesia in Europe - Constantina Politis, Greece

·       14:45 - 15:05 Cost Effectiveness Study of Pathogen Reduction/Inactivation Technology in Quebec - Marc Germain, Héma-Québec, Canada

·       15:05 - 15:15 Q&A

15:15 - 15:45 Coffee Break

15:45 - 16:30 - Session 8

Report from the Future

·       15:45 - 16:05 Monkeypox Virus – Epidemiology of an Emerging Infectious Risk - Camille Besombes, Institut Pasteur, France

·       16:05 - 16:25 Surveillance and Enhanced Diagnostics for EIDs - Nuno Faria, Imperial College, United Kingdom

·       16:25 - 16:45 Impact of Climate Change on Infectious Disease - Lyle Petersen, CDC, United States

·       16:45 - 17:00 Q&A

17:00 - 17:30 Meeting Closure

常规注册包括：会议、展览、会议资料、茶歇等

随行人员注册包括：茶歇、进入展区参观

早鸟注册:须于早期注册截止前完成注册及汇款，如汇款晚于截止日期前到达，则不能享受早鸟价

其它：会议接待、预订展位、境外研修、考察培训、海外推广、机票酒店预定、翻译、境外接送机、会后旅行等请联系我们

参会流程：点击立即报名或联系客服，提交需求客服联系参会人沟通->>确定代办业务并签订合同->>付款->>操作代办业务->>顺利出行

支付方式：线上支付（请联系客服）线下支付请前往银行柜台支付您的参会费用

汇款账号及注意事项

单位名称：领域国际商务服务（北京）有限公司

银行名称：招行北京青年路支行

银行账号：110923888910803

注意事项：转账汇款时，请务必确认收款信息是否正确，并填写备注说明，确保填写完整参会，参会人姓名+会议简称+款项用途（例：姓名+DDW+注册费）如果您的汇款信息不完整，会导致无法识别该笔汇款出处。如果您进行银行转账，请务必提供银行汇款单作为证明，以便追踪款项，请将汇款单发送至lingyumed@126.com,一旦确认汇款，注册将在24小时内被确认。

如果汇款后3个工作日内未与您确认订单收款，请及时与我们联系！

联系电话：010-57571855

会议报名咨询：010-57571855 18911270084